COMP <GO>
ANNA vs CVX // ALTMAN Z-SCORE & DEBT/EQUITY
AleAnna Inc. (Class A) (NASDAQ) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: ANNA 4
— CVX 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: CVX
LAST: $2.44 (-0.81%) • MKT CAP: $163.3M
balance-sheet
0.23
LAST: $231.46 (+0.99%) • MKT CAP: $457.31B
balance-sheet
3.71
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANNA VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANNA | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 41.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.50% | 5.80% | +2.70 | ANNA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 45.3x | 21.5x | +23.80 | CVX | /valuation <GO> |
| Free Cash Flow Yield | 6.22% | 5.61% | +0.61 | ANNA | /fcf-yield <GO> |
| Operating Margin | 11.60% | 8.10% | +3.50 | ANNA | /operating-margins <GO> |
| Net Profit Margin | — | 6.70% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | -4.60% | +184.60 | ANNA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.79% | -2.79 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.23 | 3.71 | -3.48 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | CVX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.5 | 64.7 | -24.20 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.07 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 34.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $163.3M | $457.31B | -$457.15B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANNA REV | CVX REV | ANNA GROSS % | CVX GROSS % | ANNA FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $25.0M | $184.43B | — | 41.3% | $10.2M | $25.64B |
| FY 2024 | $1.4M | $193.41B | — | 38.4% | -$16.9M | $22.79B |
| FY 2023 | $0 | $196.91B | — | — | -$5.7M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANNA // BETA —
CVX // BETA 1.07